Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Vor Biopharma Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −1 vs. Q2 2022
- Shares held
- 31.5M
- +386.6K (+1.2%) vs. Q2 2022
- Total value
- $125.5M
- −$29.3M (−18.9%) vs. Q2 2022
- New holders
- 8
- 13 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 11,120,973 | $44.3M | 0.94% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 6,361,723 | $25.3M | 4.85% | 00.0% | Unchanged |
| FMR LLC | 3,181,235 | $12.7M | 0.00% | −4,418−0.1% | Reduced |
| Paradigm Biocapital Advisors LP | 1,703,645 | $6.78M | 0.95% | +399,345+30.6% | Added |
| Baker Bros. Advisors LP | 1,465,925 | $5.83M | 0.04% | +327,157+28.7% | Added |
| Woodline Partners LP | 1,111,123 | $4.42M | 0.06% | 00.0% | Unchanged |
| Johnson & Johnson | 1,074,658 | $4.28M | 1.26% | 00.0% | Unchanged |
| Laurion Capital Management LP | 857,308 | $3.41M | 0.09% | 00.0% | Unchanged |
| Vanguard Group Inc | 657,142 | $2.62M | 0.00% | 00.0% | Unchanged |
| Sarissa Capital Management LP | 618,000 | $2.46M | 0.28% | 00.0% | Unchanged |
| Artal Group S.A. | 550,000 | $2.19M | 0.11% | 00.0% | Unchanged |
| BlackRock Inc. | 437,621 | $1.74M | 0.00% | −2,497−0.6% | Reduced |
| OUP Management Co., LLC | 374,714 | $1.49M | 2.32% | 00.0% | Unchanged |
| Millennium Management LLC | 338,921 | $1.35M | 0.00% | +49,979+17.3% | Added |
| Thrivent Financial for Lutherans | 302,412 | $1.20M | 0.00% | +15,560+5.4% | Added |
| Ally Bridge Group (NY) LLC | 255,162 | $1.02M | 0.67% | +255,162 | New |
| Ensign Peak Advisors, Inc | 209,500 | $834.0K | 0.00% | +209,500 | New |
| Geode Capital Management, LLC | 135,598 | $539.0K | 0.00% | +28,223+26.3% | Added |
| JPMorgan Chase & Co | 129,080 | $514.0K | 0.00% | −42,297−24.7% | Reduced |
| OrbiMed Advisors LLC | 111,808 | $445.0K | 0.01% | −721,525−86.6% | Reduced |
| Bridgeway Capital Management, LLC | 79,400 | $316.0K | 0.01% | +10,000+14.4% | Added |
| Ergoteles LLC | 65,332 | $260.0K | 0.01% | −21,091−24.4% | Reduced |
| Bollard Group LLC | 55,555 | $221.0K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 46,660 | $186.0K | 0.00% | +25,148+116.9% | Added |
| State Street Corp | 41,213 | $164.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 32,945 | $131.0K | 0.00% | +32,945 | New |
| Renaissance Technologies LLC | 31,900 | $127.0K | 0.00% | +14,600+84.4% | Added |
| LMR Partners LLP | 26,768 | $107.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 23,122 | $92.0K | 0.00% | +4,096+21.5% | Added |
| Citadel Advisors LLC | 22,397 | $89.0K | 0.00% | −56,977−71.8% | Reduced |
| Goldman Sachs Group Inc | 19,062 | $76.0K | 0.00% | −8,470−30.8% | Reduced |
| Chicago Partners Investment Group LLC | 14,549 | $66.0K | 0.00% | +1,659+12.9% | Added |
| Qube Research & Technologies Ltd | 14,834 | $59.0K | 0.00% | −1,463−9.0% | Reduced |
| Two Sigma Investments, LP | 14,606 | $58.0K | 0.00% | +14,606 | New |
| Charles Schwab Investment Management Inc | 10,875 | $44.0K | 0.00% | −30,601−73.8% | Reduced |
| Bourgeon Capital Management LLC | 10,700 | $43.0K | 0.01% | +3,000+39.0% | Added |
| Jane Street Group, LLC | 10,412 | $41.0K | 0.00% | +10,412 | New |
| Morgan Stanley | 7,672 | $30.0K | 0.00% | −22,598−74.7% | Reduced |
| Nisa Investment Advisors, LLC | 3,900 | $19.0K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,433 | $13.0K | 0.00% | +3,433 | New |
| Bank of America Corp | 1,699 | $7.00K | 0.00% | +244+16.8% | Added |
| Royal Bank of Canada | 1,572 | $6.00K | 0.00% | +1,572 | New |
| Citigroup Inc | 446 | $2.00K | 0.00% | −313−41.2% | Reduced |
| Northwestern Mutual Wealth Management Co | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Eagle Bay Advisors LLC | 150 | $1.00K | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 356 | $1.00K | 0.00% | +356 | New |
| Daiwa Securities Group Inc. | 109 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 110 | $0 | 0.00% | +40+57.1% | Added |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −53,074−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −16,132−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −14,856−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,252−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −10,800−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −865−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |